Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
Clinically isolated syndromes and the relationship to multiple sclerosis.
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS?
PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews.
RNF and Betaseron® Tolerability Study (REFORMS)
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Immune cell trafficking from the brain maintains CNS immune tolerance.
Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis.
Anti-integrin therapy for multiple sclerosis.
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis.
The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients.
Circulating mitochondrial DAMPs cause inflammatory responses to injury.
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.
The effect of an AFO-shaped elastic band on drop-foot gait in patients with central neurological lesions.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: The particular context of virus infection.
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.
Placebo power.
Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies.
Successful treatment of psoriasis with ustekinumab in patients with multiple sclerosis.
Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS.
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.
N-Acetylcysteine amide: A Derivative to Fulfill the Promises of N-Acetylcysteine.
Pages
« first
‹ previous
…
136
137
138
139
140
141
142
143
144
…
next ›
last »